Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-30.77
Price to sales ratio
13.04

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
486
LH
Labcorp Holdings Inc. Common Stock
336.60 USD+0.28%+0.93%+7.74%+20.59%27.30 B USD
493
DGX
Quest Diagnostics Incorporated Common Stock
244.63 USD-0.16%+2.10%+4.22%+36.18%27.00 B USD
662
MEDP
Medpace Holdings, Inc. - Common Stock
611.57 USD-1.21%-0.42%+7.13%+0.82%17.07 B USD
729
RVTY
Revvity, Inc. Common Stock
129.67 USD+2.61%+4.57%+16.40%+36.70%14.47 B USD

Frequently asked questions about Guardant Health, Inc. Common Stock

What is the Guardant Health, Inc. Common Stock stock price today?

The current price of Guardant Health, Inc. Common Stock (GH) is 168.52. Over the past 24 hours, the stock has changed by -1.40%. Follow the GH chart for real-time price dynamics.

What is the stock ticker of Guardant Health, Inc. Common Stock?

Guardant Health, Inc. Common Stock trades under the ticker GH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Guardant Health, Inc. Common Stock stock going up?

GH has changed by +0.32% over the last week, +17.34% over the last month, and +132.25% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Guardant Health, Inc. Common Stock?

Guardant Health, Inc. Common Stock currently has a market capitalization of 22.61 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Guardant Health, Inc. Common Stock earnings last quarter?

Last quarter, Guardant Health, Inc. Common Stock reported earnings of -0.9 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Guardant Health, Inc. Common Stock revenue for the last quarter?

Guardant Health, Inc. Common Stock reported quarterly revenue of 334.98 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Guardant Health, Inc. Common Stock net income for the last quarter?

Guardant Health, Inc. Common Stock reported net income of -120.14 M for the last quarter. The previous quarter showed -112.08 M, which means net income changed by -7.20%.

How many employees does Guardant Health, Inc. Common Stock have?

As of the latest available data, Guardant Health, Inc. Common Stock has 2 506 employees. Workforce size can provide additional context about the company's scale and operations.

What is Guardant Health, Inc. Common Stock EBITDA?

Guardant Health, Inc. Common Stock EBITDA is -119.56 M, and its EBITDA margin is -35.69%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Guardant Health, Inc. Common Stock stock?

You can buy Guardant Health, Inc. Common Stock (GH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Guardant Health, Inc. Common Stock stock?

Investing in Guardant Health, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GH chart and related analysis on metatrader.com as part of your research.

Guardant Health, Inc. - Common Stock

Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.

News